Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gemifloxacin vs Cefotaxime in Spontaneous Bacterial Peritonitis
NCT04168099Phase 3Recruiting
- Sponsor
- Tanta University
- Start
- Dec 2018
- Primary completion
- Dec 2028
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of gemifloxacin in spontaneous bacterial peritonitis (SBP), sponsored by Tanta University. Started Dec 2018; status: recruiting.
02
Drugs
gemifloxacin
03
Conditions
spontaneous bacterial peritonitis (SBP)
Beyond the preview
Go deeper on NCT04168099.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04168099.